PO Box MS 9203
WVU Department of Pathology
1 Medical Center Drive
- View Website
- West Virginia University School of Medicine
- Clinical Faculty
Program 3: Alexander B. Osborn Hematopoietic Malignancy and Transplantation
- MD, University of Minnesota
- AP/CP, University of Minnesota
- Hemepath, University of Minnesota
- BS, University of Minnesota
Ten Most Recent:
High-fat, high-calorie diet enhances mammary carcinogenesis and local inflammation in MMTV-PyMT mouse model of breast cancer.
Cowen S, McLaughlin SL, Hobbs GR, Coad JE, Martin KH, Olfert IM, Vona-Davis LC.
Cancers (Basel). 2015;7(3):1125-1142.
RepSox slows decay of CD34+ AML cells and decreasesTim-3 expression.
Jajosky AN, Coad JE, Vos JA, Martin KH, Senft JR, Wenger SL, Gibson LF.
Stem Cells Transl Med. 2014;3(7):836-848.
PMCJournal - In Process.
Successful vapor-based endometrial ablation: in vivo peri-hysterectomy study.
Garza-Leal J, Hernandez I, Castillo L, Jessop ML, Chill N, Coad JE.
J Minim Invasive Gynecol. 2011;18(4):445-448.
AFAP1L1 is a novel adaptor protein of the AFAP family that interacts with cortactin and localizes to invadosomes.
Snyder BN, Cho Y, Qian Y, Coad JE, Flynn DC, Cunnick JM.
Eur J Cell Biol. 2011;90(5):376-389.
VE-cadherin and PECAM-1 enhance ALL migration across brain microvascular endothelial cell monolayers.
Akers SM, O'Leary HA, Minnear FL, Craig M, Vos JA, Coad JE, Gibson LF.
Exp Hematol. 2010;38(9):733-743.
A polymorphic variant of AFAP-110 enhances cSrc activity.
Clump DA, Yu JJ, Cho Y, Gao R, Jett J, Zot HM, Cunnick JM, Snyder B, Clump AC, Dodrill M, Gannett PM, Coad JE, Shurina R, Figg WD, Reed E, Flynn DC.
Transl Oncol. 2010;3(4):276-285.
VE-cadherin regulates Philadelphia chromosome positive acute lymphoblastic leukemia sensitivity to apoptosis.
O'Leary HA, Akers SM, Piktel D, Walton C, Fortney JE, Martin KH, Craig M, Coad JE, Gibson LF.
Cancer Microenviron. 2010;3(1):67-81.
Greenlight photoselective 120-watt 532-nm lithium triborate laser vaporization prostatectomy in living canines.
Malek RS, Kang HW, Coad JE, Koullick E.
J Endourol. 2009;23(5):837-845.
Comparison of four energy-based vascular sealing and cutting instruments: a porcine model.
Person B, Vivas DA, Ruiz D, Talcott M, Coad JE, Wexner SD.
Surg Endosc. 2008;22(2):534-538.
SHP2 is up-regulated in breast cancer cells and in infiltrating ductal carcinoma of the breast, implying its involvement in breast oncogenesis.
Zhou XD, Coad JE, Ducatman BS, Agazie YM.
- Director, Pathology Laboratory for Translational Medicine
- Director, Post-Sophomore Fellowship Program
- Director, Scholars in Pathology Sciences
Alexander B. Osborn Hematopoietic Malignancy and Transplantation Program
Dr. James Coad is a board certified anatomic and clinical pathologist with over 15 years of experience in human/animal research pathology. He is the Director of the Pathology Laboratory for Translational Medicine at West Virginia University. This laboratory serves as the University’s core tissue bank and histology laboratory and provides both the local and national research communities with the access to high quality tissues, processing and histology techniques. Thus, Dr. Coad has extensive experience in collecting, preserving, staining and evaluating both human and animal tissues. He is particularly interested in immunohistochemical and FISH staining methods to locate targeted protein expression (tumor vs adjacent tissues) and an interest in correlating animal models of malignancy with actual human tumor tissues. In addition to his general interests, he has a focus on hematological malignancies, solid organ tumors and the pathology of medical devices.
Patient Care Information
American Board of PathologyAnatomic Pathology and Clinical Pathology
American Board of PathologyHematology
Residency, Anatomic and Clinical Pathology Residency
University of Minnesota, 1996
University of Minnesota, 1997
Fellowship, Surgical Pathology
University of Minnesota, 1998